[1] Sarma J, Laan CA, Alam S, et al.Increased platelet binding to circulating monocytes in acute coronary syndromes[J]. Circulation, 2002, 105(18): 2166-2171. [2] Ammirati E, Moroni F, Norata GD, et al.Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis[J]. Mediators Inflamm, 2015.DOI:10.1155/2015/718329. [3] Arnaoutoglou E, Kouvelos G, Tzimas P, et al.Relationship between normal preoperative white blood cell count and major adverse events after endovascular repair for abdominal aortic aneurysm: results of a pilot study[J]. J Clin Anesth, 2017(36):201-205. [4] Horne BD, Anderson JL, John JM, et al.Which white blood cell subtypes predict increased cardiovascular risk?[J]. J Am Coll Cardiol, 2005, 45(10): 1638-1643. [5] İdil-Soylu A, Arıkan-Cortcu S, Uzunkaya F, et al.The correlation of the platelet-to-lymphocyte ratio with the severity of stenosis and stroke in patients with carotid arterial disease[J]. Vascular, 2017, 25(3): 299-306. [6] Hansson GK.Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 352(16): 1685-1695. [7] Aviv A, Levy D.Hemothelium, Clonal Hematopoiesis of Indeterminate Potential, and Atherosclerosis[J]. Circulation, 2019, 139(1): 7-9. [8] Prasad K.Pathophysiology and Medical Treatment of Carotid Artery Stenosis[J]. TInt J Angiol, 2015, 24(3): 158-172. [9] Guo J, Muldoon MF, Brooks MM, et al.Prognostic Significance of Pulse Pressure and Other Blood Pressure Components for Coronary Artery Disease in Type 1 Diabetes[J]. Am J Hypertens, 2019, 32(11): 1075-1081. [10] Catapano AL, Graham I, De Backer G, et al.2016 ESC/EAS Guidelines for the Management of Dyslipidaemias[J]. Rev Esp Cardiol (Engl Ed), 2017, 70(2): 115. [11] Y Park, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues[J]. Platelets, 2002, 13(5-6): 301-306. [12] Kurtul A, Murat SN, Yarlioglues M, et al.Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes[J]. Am J Cardiol, 2014, 114(7): 972-978. [13] Gawaz M, Langer H, May AE.Platelets in inflammation and atherogenesis[J]. J Clin Invest, 2005, 115(12): 3378-3384. [14] İdil-Soylu A, Arıkan-Cortcu S, Uzunkaya F, et al.The correlation of the platelet-to-lymphocyte ratio with the severity of stenosis and stroke in patients with carotid arterial disease[J]. Vascular, 2017, 25(3): 299-306. [15] Massiot N, Lareyre F, Voury-Pons A, et al.High Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with Symptomatic Internal Carotid Artery Stenosis[J]. J Stroke Cerebrovasc Dis, 2019, 28(1): 76-83. [16] Corriere T, Di Marca S, Cataudella E, et al.Neutrophil-to-Lymphocyte Ratio is a strong predictor of atherosclerotic carotid plaques in older adults[J]. Nutr Metab Cardiovasc Dis, 2018, 28(1): 23-27. [17] Xueqin L, Jun S, Zhenghong L, et al.High neutrophil-to-lymphocyte ratio is associated with increased carotid artery intima-media thickness in type 2 diabetes[J]. J Diabetes Investig, 2017, 8(1): 101-107. [18] Erkan Köklü, Yüksel İsa-Öner, Arslan Şakir, et al. Is elevated neutrophil-to-lymphocyte ratio a predictor of stroke in patients with intermediate carotid artery stenosis?[J]. J Stroke Cerebrovasc Dis, 2016, 25(3): 578-584. [19] Kadoya M, Koyama H, Kurajoh M, et al.Sleep, cardiac autonomic function, and carotid atherosclerosis in patients with cardiovascular risks: HSCAA study[J]. Atherosclerosis, 2015, 238(2): 409-414. [20] 陈忠,杨耀国. 颈动脉狭窄诊治指南[J]. 中国血管外科杂志(电子版),2017,9(3):169-175. [21] Varım C, Varım P, Acar BA, et al.Usefulness of the platelet-to-lymphocyte ratio in predicting the severity of carotid artery stenosis in patients undergoing carotid angiography[J]. Kaohsiung J Med Sci, 2016, 32(2): 86-90. [22] Massiot N, Lareyre F, Voury-Pons A, et al.High Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with Symptomatic Internal Carotid Artery Stenosis[J]. JJ Stroke Cerebrovasc Dis, 2019, 28(1): 76-83. |